Dec 15 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- INTENTION TO WITHDRAW TAKEOVER OFFER FOR HEALIUS
- NO LONGER BELIEVES OFFER CONSIDERATION OF 0.74 ACL SHARES FOR EACH HEALIUS SHARE FAIRLY REFLECTS RELATIVE CONTRIBUTION
- ACL BOARD IS CONCERNED BASED ON 1H GUIDANCE THAT HEALIUS IS AT RISK OF A SIGNIFICANT STATUTORY NPAT LOSS IN 1H FY24
- CONTINUES TO BELIEVE BENEFITS OF A MERGER BETWEEN ACL AND HEALIUS ARE COMPELLING
- ALSO NOTES THAT ACCC TODAY ANNOUNCED THAT IT OPPOSES COMBINATION OF ACL AND HEALIUS
- REMAINS OPEN TO A MERGER BETWEEN CO & HEALIUS
- ACL BOARD INTENDS TO CLOSELY MONITOR PERFORMANCE OF HEALIUS IN COMING MONTHS & REMAINS OPEN TO MERGER BETWEEN 2 COMPANIES
- CONCERNED BASED ON 1H GUIDANCE THAT HEALIUS IS AT RISK OF A SIGNIFICANT STATUTORY NPAT LOSS IN 1H FY24
- DECISION BY ACCC GIVES CO ABILITY TO CHALLENGE ACCC'S POSITION DIRECTLY IN COURT IF IT MAKES A NEW OFFER IN NEAR FUTURE
Dec 15 (Reuters) - Australian Clinical Labs Ltd (ACL) :...
Add ACL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.44 |
Change
-0.010(0.41%) |
Mkt cap ! $492.4M | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.49 | $2.43 | $2.172M | 886.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2650 | $2.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.48 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.45 |
Change
-0.010 ( 0.22 %) |
||||
| Open | High | Low | Volume | ||
| $2.47 | $2.49 | $2.44 | 124278 | ||
| Last updated 15.59pm 16/05/2024 ? | |||||
| ACL (ASX) Chart |